Caris Life Sciences (CAI) Other Non-Current Liabilities (2024 - 2026)

Caris Life Sciences' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $43.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $43.6 million; the TTM figure through Mar 2026 stood at $43.6 million (changed N/A YoY), while the FY2025 annual figure was $42.4 million, down 53.75% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $43.6 million, up from $42.4 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $91.6 million in Q4 2024, with the low at $42.4 million in Q4 2025.
• The 3-year median for Other Non-Current Liabilities is $43.6 million (2026), against an average of $59.2 million.
• Peak annual rise in Other Non-Current Liabilities reached 53.75% in 2025, while the deepest fall reached 53.75% in 2025.
• Caris Life Sciences' Other Non-Current Liabilities stood at $91.6 million in 2024, then slumped by 53.75% to $42.4 million in 2025, then advanced by 2.86% to $43.6 million in 2026.
• Business Quant data shows CAI's Other Non-Current Liabilities at $43.6 million in Q1 2026, $42.4 million in Q4 2025, and $91.6 million in Q4 2024.